14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SCL vs MATV: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Mativ Holdings, Inc. (MATV) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SCL carries a Unified Composite Score of 40.7/100 (SELL) at $66.68 (18.9x Forward P/E, 3.5% operating margin), whereas MATV carries 52.8/100 (HOLD) at $11.67 (10.2x Forward P/E, 4.1% operating margin).
Growth vs. Quality Trade-Off: MATV earns the overall head-to-head edge with a stronger Unified Composite Score (52.8/100 HOLD vs. SCL 40.7/100 SELL) and 0.77β · 52% Vol risk profile, whereas SCL leads top-line expansion (+17.3% YoY revenue growth, 1.75x PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: SCL trades in a Markup technical trend (CONSOLIDATION options phase, RSI 51.4); meanwhile MATV is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SCL vs MATV. Trailing 12-month operating profitability (SCL 3.5% vs MATV 4.1%) and valuation multiples (SCL 18.9x vs MATV 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Specialty Chemicals value chain with $662.9M market capitalization and 4.1% operating margin.
OpEx & R&D Reinvestment15.3% of Rev ($302M)
90D Engineering Disclosures0 Published
Investor FAQ SCL vs MATV Key Questions & Quantitative Answers
As of Nov 16, 2026, Mativ Holdings, Inc. (MATV) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SCL carries a Unified Composite Score of 40.7/100 (SELL) at $66.68 (18.9x Forward P/E, 3.5% operating margin), whereas MATV carries 52.8/100 (HOLD) at $11.67 (10.2x Forward P/E, 4.1% operating margin). Growth vs. Quality Trade-Off: MATV earns the overall head-to-head edge with a stronger Unified Composite Score (52.8/100 HOLD vs. SCL 40.7/100 SELL) and 0.77β · 52% Vol risk profile, whereas SCL leads top-line expansion (+17.3% YoY revenue growth, 1.75x PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: SCL trades in a Markup technical trend (CONSOLIDATION options phase, RSI 51.4); meanwhile MATV is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SCL leads the Growth & Scale pillar: SCL posts +17.3% YoY revenue growth and +65.5% YoY earnings growth on $2.53B TTM revenue (12.0% gross margin, 3.5% operating margin), compared with MATV at -2.8% YoY revenue growth and N/A YoY earnings growth on $1.97B TTM revenue (19.4% gross margin, 4.1% operating margin). On trailing 12-month operating scale, SCL generates $2.53B in USD-normalized revenue versus $1.97B for MATV. In operating R&D and SG&A reinvestment, SCL deploys 8.5% of Rev ($215M) (0 90-day corporate R&D disclosures) versus 15.3% of Rev ($302M) (0 disclosures) for MATV.
MATV screens cheaper on headline valuation multiples. SCL trades at 18.9x Forward P/E, N/M Trailing P/E, 1.75x PEG, and 0.8x EV/Revenue (0.2% FCF margin), whereas MATV trades at 10.2x Forward P/E, 7.2x Trailing P/E, 1.84x PEG, and 0.3x EV/Revenue (10.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SCL (0.4% ROE) versus MATV (21.2% ROE) capital efficiency.
In options market volatility and institutional positioning, SCL carries 32.0% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.52β · 31% Vol realized risk). By comparison, MATV carries 56.0% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.77β · 52% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.